Search
                    Cisplatin Treatment Options in Wisconsin
A collection of 243 research studies where Cisplatin is the interventional treatment. These studies are located in the Wisconsin, United States. Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-Small Cell Lung Cancer.
            217 - 228 of 243
        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed neuroblastoma.             
        
        
    Gender:
                ALL
            Ages:
                30 years and below
            Trial Updated:
                02/12/2014
            
            Locations: CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin         
        
        
            Conditions: Neuroblastoma
        
            
        
    
                
                                    Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
                                
            
            
        Completed
                            
            
                RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy plus cisplatin is more effective than radiation therapy alone in treating patients with head and neck cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy plus cisplatin with radiation therapy alone in treating patients with he...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                01/23/2014
            
            Locations: Medical College of Wisconsin, Milwaukee, Wisconsin  +1 locations         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
                                
            
            
        Unknown
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if treatment with cisplatin plus epinephrine is effective for head and neck cancer.
PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of cisplatin plus epinephrine in injectable gel form in treating patients who have recurrent or refractory head and neck cancer.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/18/2013
            
            Locations: Department of Otolaryngology, Milwaukee, Wisconsin         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
                                
            
            
        Unknown
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Bone marrow transplantation may allow doctors to give higher doses of radiation therapy and chemotherapy and kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of high-dose etoposide and cyclophosphamide plus total-body irradiation followed by bone marrow transplantation in treating pati...  Read More             
        
        
    Gender:
                ALL
            Ages:
                16 years and above
            Trial Updated:
                12/17/2013
            
            Locations: St. Luke's Medical Center, Milwaukee, Wisconsin         
        
        
            Conditions: Lymphoma
        
            
        
    
                
                                    Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
                                
            
            
        Unknown
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs such as amifostine may protect normal cells from the side effects of chemotherapy.
PURPOSE: Phase I/II trial to study the effectiveness of combining docetaxel, cisplatin, and amifostine in treating patients who have advanced non-small cell lung cancer that cannot be surgically removed.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/03/2013
            
            Locations: University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin         
        
        
            Conditions: Drug/Agent Toxicity by Tissue/Organ, Lung Cancer
        
            
        
    
                
                                    Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving radiation therapy in different ways and combining it with chemotherapy may kill more tumor cells. Celecoxib may slow the growth of cervical cancer by stopping blood flow to the tumor.
PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy plus celecoxib, fluorouracil, and cisplatin in tr...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                Between 18 years and 85 years
            Trial Updated:
                11/18/2013
            
            Locations: CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin         
        
        
            Conditions: Cervical Cancer
        
            
        
    
                
                                    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of radiation therapy plus combination chemotherapy in treating patients with limited-stage small cell lung cancer.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                10/31/2013
            
            Locations: St. Vincent Hospital, Green Bay, Wisconsin  +12 locations         
        
        
            Conditions: Lung Cancer
        
            
        
    
                
                                    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy, such as cisplatin, etoposide, and docetaxel, use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining cisplatin and etoposide with radiation therapy may shrink the tumor so it can be removed by surgery. Giving docetaxel after surgery may kill any remaining tumor cells.
PURPOSE: This phase II trial is studying how well giving chemoradiotherapy together with c...  Read More             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                10/30/2013
            
            Locations: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin         
        
        
            Conditions: Lung Cancer
        
            
        
    
                
                                    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effect on the body of combining cyclophosphamide with cisplatin, etoposide, and bleomycin in treating children who have newly diagnosed malignant germ cell tumors that are not in the brain and gonads.             
        
        
    Gender:
                ALL
            Ages:
                21 years and below
            Trial Updated:
                10/15/2013
            
            Locations: St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin  +3 locations         
        
        
            Conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
        
            
        
    
                
                                    Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
                                
            
            
        Completed
                            
            
                This study is testing the investigational drug, cetuximab, in combination with different chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug combinations looks most promising and should be tested further. The study will also look at what side effects may occur.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/11/2013
            
            Locations: Not set, Wauwatosa, Wisconsin         
        
        
            Conditions: Non-Small Cell Lung Cancer
        
            
        
    
                
                                    Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy, such as carboplatin and vincristine, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining carboplatin and vincristine with radiation therapy followed by adjuvant chemotherapy may kill more tumor cells.
PURPOSE: Randomized phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy followed adjuvant chemotherapy in tre...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 3 years and 21 years
            Trial Updated:
                08/22/2013
            
            Locations: University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin         
        
        
            Conditions: Brain Tumors, Central Nervous System Tumors, Neuroblastoma
        
            
        
    
                
                                    Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
                                
            
            
        Completed
                            
            
                This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy. One treatment will use an investigational drug in combination with an FDA approved chemotherapy. The other treatment will use a combination of two FDA approved chemotherapy drugs.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/20/2013
            
            Locations: GSK Clinical Trials Call Center, Madison, Wisconsin         
        
        
            Conditions: Small Cell Lung Cancer
        
            
        
    217 - 228 of 243
            